Clinical Trial Update: Aspirin Resistance in Systemic Lupus Erythematosus (SLE) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating aspirin resistance in patients with Systemic Lupus Erythematosus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Vanderbilt University | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED